These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events. Vianna AC, Mocelin AJ, Matsuo T, Morais-Filho D, Largura A, Delfino VA, Soares AE, Matni AM. Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173 [Abstract] [Full Text] [Related]
7. Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial. Bostom AG, Carpenter MA, Kusek JW, Hunsicker LG, Pfeffer MA, Levey AS, Jacques PF, McKenney J, FAVORIT Investigators. Am Heart J; 2006 Sep; 152(3):448.e1-7. PubMed ID: 16923411 [Abstract] [Full Text] [Related]
8. [The role of hyperhomocysteinemia on atherosclerosis in patients with chronic renal failure]. Yu Y, Hou F, Zhou H, Yang Y, Zhang X, Yang L, Hu M. Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):517-21. PubMed ID: 12421497 [Abstract] [Full Text] [Related]
11. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years. Wolters M, Hermann S, Hahn A. Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436 [Abstract] [Full Text] [Related]
12. [Hyperhomocysteinemia, oxidative stress and microinflammation in chronic renal failure: their roles in atherogene]. Yu YM, Hou FF, Zhang X, Zhou H, Liu ZQ. Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):292-5. PubMed ID: 15130417 [Abstract] [Full Text] [Related]
14. Homocysteine is not associated with arterial thickness and stiffness in healthy middle-aged French volunteers. de Bree A, Mennen LI, Zureik M, Ducros V, Guilland JC, Nicolas JP, Emery-Fillon N, Blacher J, Hercberg S, Galan P. Int J Cardiol; 2006 Nov 18; 113(3):332-40. PubMed ID: 16364473 [Abstract] [Full Text] [Related]
15. Pulse wave velocity--a useful tool for cardiovascular surveillance in pre-dialysis patients. Lemos MM, Jancikic AD, Sanches FM, Christofalo DM, Ajzen SA, Miname MH, Santos RD, Fachini FC, Carvalho AB, Draibe SA, Canziani ME. Nephrol Dial Transplant; 2007 Dec 18; 22(12):3527-32. PubMed ID: 17704115 [Abstract] [Full Text] [Related]
16. Homocysteine and carotid atherosclerosis in chronic renal failure--the confounding effect of renal function. Leskinen Y, Lehtimäki T, Loimaala A, Huhtala H, Salenius JP, Oja SS, Saha H. Atherosclerosis; 2004 Aug 18; 175(2):315-23. PubMed ID: 15262188 [Abstract] [Full Text] [Related]
17. Association of pulse pressure with carotid atherosclerosis in patients with type 2 diabetes mellitus. Wakabayashi I, Masuda H. Blood Press; 2007 Aug 18; 16(1):56-62. PubMed ID: 17453753 [Abstract] [Full Text] [Related]
18. Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure. Chauveau P, Chadefaux B, Coudé M, Aupetit J, Kamoun P, Jungers P. Miner Electrolyte Metab; 1996 Aug 18; 22(1-3):106-9. PubMed ID: 8676798 [Abstract] [Full Text] [Related]
19. Pulse wave velocity and coronary risk stratification. Mendonça MI, Reis RP, Sousa AC, Gomes S, Faria P, Pereira A, Silva B, Serrão M, Santos N, Sousa FS, Silva JA, Sousa J, Ornelas I, Freitas S, Cardoso A, Araújo JJ. Rev Port Cardiol; 2009 Feb 18; 28(2):155-71. PubMed ID: 19438151 [Abstract] [Full Text] [Related]
20. Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. Mangoni AA, Sherwood RA, Asonganyi B, Swift CG, Thomas S, Jackson SH. Am J Hypertens; 2005 Feb 18; 18(2 Pt 1):220-6. PubMed ID: 15752950 [Abstract] [Full Text] [Related] Page: [Next] [New Search]